Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide-Reference-Cited by-同舟云学术

Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide

Published:2005-12 Issue:12 Volume:26 Page:2458-2463
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Fernandes Liliam,Loiola Rodrigo Azevedo,Tostes Rita C.A.,Nigro Dorothy,Fortes Zuleica Bruno,de Carvalho Maria Helena Catelli

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference35 articles.

1. Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors;Campos;J Pharmacol Exp Ther,1994

2. International Union of Pharmacology XXIII The Angiotensin II receptors;De Gasparo;Pharmacol Rev,2000

3. Studies on the relationship between flow resistance, capillary filtration coefficient and regional blood volume in the intestine of the cat;Folkow;Acta Physiol Scand,1963

4. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension;Goa;Drugs,1996

5. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition;Kambayashi;J Biol Chem,1993

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous endothelial function in cardiovascular disease;Bioscience Reports;2022-11

2. Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism;Reviews in Cardiovascular Medicine;2021

3. Venous endothelium reactivity to Angiotensin II: A study in primary endothelial cultures of rat vena cava and portal vein;Experimental Cell Research;2018-01

4. Prostanoids counterbalance the synergism between endothelin-1 and angiotensin II in mesenteric veins of trained rats;Peptides;2017-02

5. Role of chymase in the local renin-angiotensin system in keloids: inhibition of chymase may be an effective therapeutic approach to treat keloids;Drug Design, Development and Therapy;2015-08